MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/iju.70507

Медицинская библиотека · International journal of urology : official journal of the Japanese Urological Association · 2026

Prognostic Significance of Pretreatment Blood-Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan.

Tatarano Shuichi, Miyake Makito, Osaki Yu, Daizumoto Kei, Wada Koichiro, Kobayashi Keita, Kato Minoru, Fukuhara Hideo, Tsujino Takuya, Kobatake Kohei, Taoka Rikiya, Furukawa Junya, Ogawa Kohei, Shiraishi Koji, Matsue Taisuke, Inoue Keiji, Maenosono Ryoichi, Sekino Yohei, Fujimoto Kiyohide, Enokida Hideki, West Japan Uro‐oncology Collaboration Group

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод в очереди

Аннотация

OBJECTIVES

Penile cancer is a rare malignancy, and multicenter data evaluating prognostic biomarkers in the Japanese population are limited. This study aimed to assess the prognostic significance of pretreatment blood-based biomarkers in patients with penile cancer.

METHODS

We conducted a multicenter retrospective cohort study including 111 patients with penile cancer treated between January 2005 and December 2023 at ten institutions participating in the West Japan Uro-oncology Collaboration Group. Cancer-specific survival (CSS) was analyzed using the Kaplan-Meier method and Cox proportional hazards model. Receiver operating characteristic analyses were performed to determine optimal cutoff values for the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and squamous cell carcinoma antigen (SCC-Ag). A composite biomarker score was calculated based on the number of elevated biomarkers.

RESULTS

The 5-year overall survival and CSS rates were 71.1% and 77.4%, respectively. In univariate analyses, elevated PLR, elevated SCC-Ag, and higher composite biomarker scores were significantly associated with poorer CSS. In multivariate analysis, advanced clinical nodal status (≥ cN2) and distant metastasis (cM1) remained independent predictors of CSS, whereas blood-based biomarkers did not retain independent prognostic significance after adjustment for established clinicopathological factors. Kaplan-Meier analyses demonstrated significantly worse CSS in patients with high PLR, high SCC-Ag levels, and higher composite biomarker scores.

CONCLUSIONS

Pretreatment blood-based biomarkers, particularly PLR and SCC-Ag, are associated with prognosis in penile cancer. Although they did not retain independent prognostic factors after adjustment, these biomarkers may provide complementary prognostic information and help identify high-risk patients in clinical practice.

Для цитирования: Tatarano Shuichi, Miyake Makito, Osaki Yu, Daizumoto Kei, Wada Koichiro, Kobayashi Keita, Kato Minoru, Fukuhara Hideo, Tsujino Takuya, Kobatake Kohei, Taoka Rikiya, Furukawa Junya, Ogawa Kohei, Shiraishi Koji, Matsue Taisuke, Inoue Keiji, Maenosono Ryoichi, Sekino Yohei, Fujimoto Kiyohide, Enokida Hideki, West Japan Uro‐oncology Collaboration Group. Prognostic Significance of Pretreatment Blood-Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan.. International journal of urology : official journal of the Japanese Urological Association. 2026. DOI: 10.1111/iju.70507.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.